Stent failure: the diagnosis and management of intracoronary stent restenosis

References

• Moussa ID, Mohananey D, Saucedo J, et al. Trends and outcomes of restenosis after coronary stent implantation in the United States. J Am Coll Cardiol. 2020;76(13):1521–1531. DOI:10.1016/j.jacc.2020.08.002
   PubMed Web of Science ®Google Scholar
• Cutlip DE, Chhabra AG, Baim DS, et al. Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials. Circulation. 2004;110(10):1226–1230. DOI:10.1161/01.CIR.0000140721.27004.4B
   PubMed Web of Science ®Google Scholar
• Dangas GD, Claessen BE, Caixeta A, et al. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol. 2010;56(23):1897–1907. DOI:10.1016/j.jacc.2010.07.028
   PubMed Web of Science ®Google Scholar
• Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation. 1999;100(18):1872–1878. DOI:10.1161/01.cir.100.18.1872
   PubMed Web of Science ®Google Scholar
• Cutlip DE, Chauhan MS, Baim DS, et al. Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. J Am Coll Cardiol. 2002;40(12):2082–2089. DOI:10.1016/s0735-1097(02)02597-4
   PubMed Web of Science ®Google Scholar
• Kimura T, Morimoto T, Nakagawa Y, et al. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry. Circulation. 2012;125(4):584–591. DOI:10.1161/CIRCULATIONAHA.111.046599
   PubMed Web of Science ®Google Scholar
• Raber L, Wohlwend L, Wigger M, et al. Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the sirolimus-eluting versus paclitaxel-eluting stents for coronary revascularization LATE trial. Circulation. 2011;123(24):2819–2828, 2816 pfollowing 2828. DOI:10.1161/CIRCULATIONAHA.110.004762
   PubMed Web of Science ®Google Scholar
• Piccolo R, Stefanini GG, Franzone A, et al. Safety and efficacy of resolute zotarolimus-eluting stents compared with everolimus-eluting stents: a meta-analysis. Circ Cardiovasc Interv. 2015;8(4).
   PubMed Web of Science ®Google Scholar
• Stefanini GG, Holmes DR Jr. Drug-eluting coronary-artery stents. N Engl J Med. 2013;368(3):254–265.
   PubMed Web of Science ®Google Scholar
• Hausleiter J, Kastrati A, Mehilli J, et al. Predictive factors for early cardiac events and angiographic restenosis after coronary stent placement in small coronary arteries. Journal Of The American College Of Cardiology. 2002;40(5):882–889. DOI:10.1016/s0735-1097(02)02043-0
   PubMed Web of Science ®Google Scholar
• Kastrati A, Schömig A, Elezi S, et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol. 1997;30(6):1428–1436. DOI:10.1016/s0735-1097(97)00334-3
   PubMed Web of Science ®Google Scholar
• Pal N, Din J, O’Kane P. Contemporary management of stent failure: part one. Interv Cardiol. 2019;14(1):10–16.
   PubMedGoogle Scholar
• Buccheri D, Piraino D, Andolina G, et al. Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment. J Thorac Dis. 2016;8(10):E1150–E1162.
   PubMed Web of Science ®Google Scholar
• Sakamoto A, Jinnouchi H, Torii S, et al. Understanding the impact of stent and scaffold material and strut design on coronary artery thrombosis from the basic and clinical points of view. Bioengineering (Basel). 2018;5(3):71.
   PubMedGoogle Scholar
• Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation. 1996;94(6):1247–1254. DOI:10.1161/01.cir.94.6.1247
   PubMed Web of Science ®Google Scholar
• Kornowski R, Hong MK, Tio FO, et al. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol. 1998;31(1):224–230. DOI:10.1016/s0735-1097(97)00450-6
   PubMed Web of Science ®Google Scholar
• Kearney M, Pieczek A, Haley L, et al. Histopathology of in-stent restenosis in patients with peripheral artery disease. Circulation. 1997;95(8):1998–2002. DOI:10.1161/01.cir.95.8.1998
   PubMed Web of Science ®Google Scholar
• Farb A, Sangiorgi G, Carter AJ, et al. Pathology of acute and chronic coronary stenting in humans. Circulation. 1999;99(1):44–52. DOI:10.1161/01.cir.99.1.44
   PubMed Web of Science ®Google Scholar
• Chung IM, Gold HK, Schwartz SM, et al. Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment. J Am Coll Cardiol. 2002;40(12):2072–2081. DOI:10.1016/s0735-1097(02)02598-6
   PubMed Web of Science ®Google Scholar
• Giustino G, Colombo A, Camaj A, et al. Coronary in-stent restenosis: jACC state-of-the-art review. J Am Coll Cardiol. 2022;80(4):348–372. DOI:10.1016/j.jacc.2022.05.017
   PubMed Web of Science ®Google Scholar
• Nakano M, Otsuka F, Yahagi K, et al. Human autopsy study of drug-eluting stents restenosis: histomorphological predictors and neointimal characteristics. Eur Heart J. 2013;34(42):3304–3313. DOI:10.1093/eurheartj/eht241
   PubMed Web of Science ®Google Scholar
• Chieffo A, Foglieni C, Nodari RL, et al. Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents. Am J Cardiol. 2009;104(12):1660–1667. DOI:10.1016/j.amjcard.2009.07.041
   PubMed Web of Science ®Google Scholar
• Otsuka F, Byrne RA, Yahagi K, et al. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. Eur Heart J. 2015;36(32):2147–2159. DOI:10.1093/eurheartj/ehv205
   PubMed Web of Science ®Google Scholar
• Kang SJ, Mintz GS, Park D-W, et al. Tissue characterization of in-stent neointima using intravascular ultrasound radiofrequency data analysis. Am J Cardiol. 2010;106(11):1561–1565. DOI:10.1016/j.amjcard.2010.07.031
   PubMed Web of Science ®Google Scholar
• Akhtar M, Liu W. Use of intravascular ultrasound vs. optical coherence tomography for mechanism and patterns of in-stent restenosis among bare metal stents and drug eluting stents. J Thorac Dis. 2016;8:E104–108.
   PubMed Web of Science ®Google Scholar
• Lopez-Palop R, PINAR E, LOZANO I, et al. Utility of the fractional flow reserve in the evaluation of angiographically moderate in-stent restenosis. Eur Heart J. 2004;25(22):2040–2047. DOI:10.1016/j.ehj.2004.07.016
   PubMed Web of Science ®Google Scholar
• Alfonso F, Pérez-Vizcayno MJ, Cuesta J, et al. 3-Year clinical follow-up of the RIBS IV clinical trial: a prospective randomized study of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis in coronary arteries previously treated with drug-eluting stents. JACC: Cardiovasc Interv. 2018;11(10):981–991. DOI:10.1016/j.jcin.2018.02.037
   PubMed Web of Science ®Google Scholar
• Windecker S, Kolh P, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for cardio-thoracic surgery (eacts)developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541–2619.
   PubMed Web of Science ®Google Scholar
• Moustapha A, Assali AR, Sdringola S, et al. Percutaneous and surgical interventions for in-stent restenosis: long-term outcomes and effect of diabetes mellitus. J Am Coll Cardiol. 2001;37(7):1877–1882. DOI:10.1016/s0735-1097(01)01231-1
   PubMed Web of Science ®Google Scholar
• Siontis GC, Stefanini GG, Mavridis D, et al. Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis. Lancet. 2015;386(9994):655–664. DOI:10.1016/S0140-6736(15)60657-2
   PubMed Web of Science ®Google Scholar
• Alfonso F, Pérez-Vizcayno MJ, Cuesta J, et al. Paclitaxel-eluting balloons or everolimus-eluting stents for in-stent restenosis. JACC: Cardiovasc Interv. 2018;11(5):505–506. DOI:10.1016/j.jcin.2017.11.032
   PubMed Web of Science ®Google Scholar
• Richards G, Johnson T. A vision of percutaneous coronary revascularisation in 2021: how to take advantage of intra-coronary imaging to perform more effective PCI. JRSM Cardiovasc Dis. 2021;10:20480040211049978.
   Web of Science ®Google Scholar